322538006: Dihydrocodeine tartrate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Opioid receptor agonist\Phenanthrene derivative\tartrate de dihydrocodéine

\Drug or medicament (substance)\Opioid receptor agonist\Phenanthrene derivative\tartrate de dihydrocodéine
\Drug or medicament (substance)\Analgesic (substance)\Phenanthrene derivative\tartrate de dihydrocodéine
\Drug or medicament (substance)\Central nervous system agent (substance)\Psychoactive substance\Central depressant\Phenanthrene derivative\tartrate de dihydrocodéine

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Hydrocarbon\Aromatic hydrocarbon\Phenanthrene (substance)\Phenanthrene derivative\tartrate de dihydrocodéine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
tartrate de dihydrocodéine	Is a	Product containing dihydrocodeine (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
tartrate de dihydrocodéine	Is a	Opiate agonist (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
tartrate de dihydrocodéine	Is a	Opioid receptor agonist	false	Inferred relationship	Existential restriction modifier (core metadata concept)
tartrate de dihydrocodéine	Is a	Dihydrocodeine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
tartrate de dihydrocodéine	Has disposition	Opioid receptor agonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
tartrate de dihydrocodéine	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
tartrate de dihydrocodéine	Is modification of (attribute)	Dihydrocodeine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
tartrate de dihydrocodéine	Is a	Phenanthrene derivative	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing dihydrocodeine tartrate and paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing aspirin and caffeine and dihydrocodeine tartrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing caffeine and dihydrocodeine tartrate and paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Dihydrocodeine tartrate 60mg m/r tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Dihydrocodeine tartrate 120mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Dihydrocodeine tartrate 90mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Dihydrocodeine tartrate 50mg/1mL injection (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	Has precise active ingredient	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet	Has precise active ingredient	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely dihydrocodeine tartrate 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection ampule	Has precise active ingredient	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection ampule	Has basis of strength substance (attribute)	False	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 30 mg oral tablet	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 30 mg oral tablet	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 10 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 2.42 milligram/1 milliliter conventional release oral solution (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 2.42 milligram/1 milliliter conventional release oral solution (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	tartrate de dihydrocodéine	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
464430016	Dihydrocodeine tartrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
716959015	Dihydrocodeine tartrate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2670322012	Dihydrocodeine bitartrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
464430016	Dihydrocodeine tartrate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
464430016	Dihydrocodeine tartrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
716959015	Dihydrocodeine tartrate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
716959015	Dihydrocodeine tartrate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2670322012	Dihydrocodeine bitartrate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2670322012	Dihydrocodeine bitartrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
35201000188119	dihydrocodéine tartrate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
806061000172114	tartrate de dihydrocodéine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
35201000188119	dihydrocodéine tartrate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
806061000172114	tartrate de dihydrocodéine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module